Editas Medicine Balance Sheet
NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Editas Medicine financial position
At the end of fiscal 2025, Editas Medicine reported total assets of $186.5 million, down 45.4% from a year earlier against total liabilities of $159.2 million. Shareholders' equity stood at $27.3 million, or 14.6% of assets. The company held $146.6 million in cash and equivalents against $58.6 million of debt, a net cash position of $88.0 million.
The current ratio (current assets divided by current liabilities) was 3.54, meaning short-term assets cover obligations due within a year. Debt-to-equity was 2.15.
Summary generated from market data by MetaCap's automated system. Methodology
Editas Medicine balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 146.65M | 131.54M | 123.65M | 141.52M | 203.52M | 139.68M | 238.18M | 134.78M | 146.63M | 185.32M |
| Short-Term Investments | 0 | 138.37M | 199.46M | 202.75M | 296.33M | 262.43M | 218.96M | 234.18M | 182.51M | — |
| Receivables | 15.18M | 16.27M | 10.19M | 5.14M | 267.00K | 6.05M | 418.00K | 30.00K | 679.00K | 88.00K |
| Total Current Assets | 163.90M | 289.31M | 340.83M | 356.75M | 507.31M | 419.09M | 463.84M | 374.78M | 332.20M | 187.18M |
| Property, Plant & Equipment | 3.54M | 14.50M | 12.03M | 15.57M | 17.12M | 14.02M | 10.89M | 40.23M | 39.44M | 40.38M |
| Long-Term Investments | — | 0 | 104.02M | 93.10M | 120.07M | 109.66M | — | — | — | — |
| Total Assets | 186.53M | 341.59M | 499.15M | 514.32M | 677.48M | 572.60M | 508.88M | 420.39M | 373.26M | 229.18M |
| Accounts Payable | 2.60M | 5.49M | 8.27M | 9.51M | 5.05M | 6.41M | 5.84M | 5.33M | 4.02M | 4.64M |
| Short-Term Debt | 5.00M | 5.00M | 0 | — | — | — | — | — | — | — |
| Total Current Liabilities | 46.25M | 77.22M | 63.22M | 60.11M | 46.88M | 58.21M | 59.96M | 35.90M | 36.71M | 33.08M |
| Long-Term Debt | 53.60M | 52.43M | 0 | — | — | — | — | — | — | — |
| Total Liabilities | 159.25M | 207.31M | 150.06M | 153.64M | 123.84M | 179.02M | 246.45M | 184.22M | 165.18M | 94.58M |
| Shareholders' Equity | 27.29M | 134.27M | 349.10M | 360.68M | 553.64M | 393.59M | 262.44M | 236.16M | 208.08M | 134.61M |
| Retained Earnings | -1.63B | -1.47B | -1.23B | -1.08B | -857.70M | -665.20M | -549.22M | -416.28M | -305.85M | -185.53M |
| Total Debt | 58.60M | 57.43M | 0 | — | — | — | — | — | — | — |
| Net Cash (Debt) | 88.04M | 212.48M | 323.11M | 344.27M | 499.85M | 402.11M | 457.14M | 368.95M | 329.14M | 185.32M |
| Shares Outstanding | 97.87M | 82.73M | 81.77M | 68.85M | 68.44M | 62.56M | 54.36M | 48.76M | 44.51M | 35.82M |
This table shows 10 annual periods of Editas Medicine's balance sheet, from FY 2025 back to FY 2016, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow EDIT's reporting calendar. What is a balance sheet?